Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jariyanart Gawee"'
Autor:
Suwanna Chaorattanakawee, Chanthap Lon, Krisada Jongsakul, Jariyanart Gawee, Somethy Sok, Siratchana Sundrakes, Nareth Kong, Chatchadaporn Thamnurak, Soklyda Chann, Sorayut Chattrakarn, Chantida Praditpol, Nillawan Buathong, Nichapat Uthaimongkol, Philip Smith, Narongrid Sirisopana, Rekol Huy, Satharath Prom, Mark M. Fukuda, Delia Bethell, Douglas S. Walsh, Charlotte Lanteri, David Saunders
Publikováno v:
Malaria Journal, Vol 15, Iss 1, Pp 1-12 (2016)
Abstract Background The recent dramatic decline in dihydroartemisinin-piperaquine (DHA-PPQ) efficacy in northwestern Cambodia has raised concerns about the rapid spread of piperaquine resistance just as DHA-PPQ is being introduced as first-line thera
Externí odkaz:
https://doaj.org/article/4e26b436c9cd4f61b0cdd86ff29d4389
Autor:
Somethy Sok, Krisada Jongsakul, Chanthap Lon, Nareth Kong, Rekol Huy, Charlotte A. Lanteri, Suwanna Chaorattanakawee, Sorayut Chattrakarn, Jariyanart Gawee, Douglas S. Walsh, Nichapat Uthaimongkol, Soklyda Chann, Philip A. Smith, David L. Saunders, Delia Bethell, Siratchana Sundrakes, Narongrid Sirisopana, Satharath Prom, Nillawan Buathong, Chatchadaporn Thamnurak, Chantida Praditpol, Mark M. Fukuda
Publikováno v:
Malaria Journal
Malaria Journal, Vol 15, Iss 1, Pp 1-12 (2016)
Malaria Journal, Vol 15, Iss 1, Pp 1-12 (2016)
Background The recent dramatic decline in dihydroartemisinin-piperaquine (DHA-PPQ) efficacy in northwestern Cambodia has raised concerns about the rapid spread of piperaquine resistance just as DHA-PPQ is being introduced as first-line therapy in nei
Autor:
Suwanna Chaorattanakawee, Chanthap Lon, Krisada Jongsakul, Jariyanart Gawee, Somethy Sok, Siratchana Sundrakes, Nareth Kong, Chatchadaporn Thamnurak, Soklyda Chann, Sorayut Chattrakarn, Chantida Praditpol, Nillawan Buathong, Nichapat Uthaimongkol, Smith, Philip, Narongrid Sirisopana, Rekol Huy, Satharath Prom, Fukuda, Mark, Bethell, Delia, Walsh, Douglas, Lanteri, Charlotte, Saunders, David
Additional file 1. Artemisinin and piperaquine susceptibility profiles do not suggest cross resistance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f61f91e9c13602e975cf15eeb644acc